Fatoumatta Darboe

Years Active: 2017-2020
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Adam Penn-Nicholson, Stanley Kimbung Mbandi, Ethan Thompson, Simon C Mendelsohn, Sara A Suliman, Novel N Chegou, Stephanus T Malherbe, Fatoumatta Darboe, Mzwandile Erasmus, Willem A Hanekom, Nicole Bilek, Michelle Fisher, Stefan H E Kaufmann, Jill Winter, Melissa Murphy, Robin Wood, Carl Morrow, Ildiko Van Rhijn, Branch Moody, Megan Murray, Bruno Bezerril Andrade, Timothy R Sterling, Jayne Sutherland, Kogieleum Naidoo, Nesri Padayatchi, Katharina Ronacher, Mark Hatherill, Daniel Zak, Thomas Jens Scriba, null null, null null, null null, null null, null null, null null, null null, null null
RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response. Scientific reports 10 (1) (2020)
Thomas Jens Scriba, Adam Penn-Nicholson, Smitha Shankar, Thomas Hraha, Ethan G Thompson, David Sterling, Elisa Nemes, Fatoumatta Darboe, Sara A Suliman, Lynn M Amon, Hassan Mahomed, Mzwandile Erasmus, Wendy Whatney, John L Johnson, W Henry Boom, Mark Hatherill, Joe Valvo, Mary Ann De Groote, Urs A Ochsner, Alan Aderem, Willem A Hanekom, Daniel E Zak, null null
Sequential inflammatory processes define human progression from M. tuberculosis infection to tuberculosis disease. PLoS pathogens 13 (11) (2017)

Fatoumatta Darboe.css-eqlu8i{font-size:small;padding-left:4px;}